Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Generex Biotechnology Corp. (GNBTQ) Message Board

I feel like this has been explained countless time

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 36563
(Total Views: 585)
Posted On: 01/30/2022 3:26:17 PM
Posted By: rjs9787
Re: Southbill #34682
I feel like this has been explained countless times. There’s lots to complain about, but the bonus one is a dead end.

Yes, Generex was planning bonuses, after all they state in the filings salaries are listed yet haven’t been paid. They planned a spin out. They planned on that finally bringing in significant funds to propel the companies and finally award BOD or employees due compensation.

The spin out hasn’t occurred.

“During the three months ended October 31, 2020, the Company awarded executives and employees bonus compensation of $7,005,416 to be paid in approximately $1 million in cash and $6 million in stock. The cash portion is to be paid out before December 31, 2020 and the stock portion is expected to be issued by January 31, 2021.”

These bonuses hence haven’t been awarded, much like past salaries weren’t awarded and are due. So, go and look at each subsequent quarterly report. The last was in June. The full amount is listed in General and Administrative Expenses in the full amount “to be” paid.

It’s not paid.

That aside, there’s always the possibility of money inappropriately going to a person. That would be something criminal. As far as we know, that’s not currently on the table. To me, what is obvious is a poor management plan on acquiring toxic (Veneto) or worthless (Hema for one) companies to be a Holding Company. That’s a bad idea because all limited resources should have gone to Ii-Key and some to Oral-Lyn (which completely stalled under Joe). Building out clinics makes no sense until cash comes in as AE37 shows success or the Covid vaccine starts real human trials.



(5)
(0)




Generex Biotechnology Corp. (GNBTQ) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us